Sartorius Aktiengesellschaft (SRT) - Total Liabilities

Latest as of March 2026: €5.98 Billion EUR ≈ $6.99 Billion USD

Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has total liabilities worth €5.98 Billion EUR (≈ $6.99 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Sartorius Aktiengesellschaft - Total Liabilities Trend (2013–2025)

This chart illustrates how Sartorius Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. See SRT net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Sartorius Aktiengesellschaft Competitors by Total Liabilities

The table below lists competitors of Sartorius Aktiengesellschaft ranked by their total liabilities.

Company Country Total Liabilities
Clearwater Analytics Holdings Inc
NYSE:CWAN
USA $972.29 Million
Shanghai Electric Power Co Ltd
SHG:600021
China CN¥149.90 Billion
Telekom Malaysia Bhd
KLSE:4863
Malaysia RM23.84 Million
Wan Hai Lines Ltd
TW:2615
Taiwan NT$133.14 Billion
Silergy Corp
TW:6415
Taiwan NT$7.45 Billion
Lottomatica Group SpA
NYSE:LOTMY
USA $3.13 Billion
STAG Industrial Inc
NYSE:STAG
USA $3.40 Billion
Flughafen Zurich
SW:FHZN
Switzerland CHF2.42 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Sartorius Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Sartorius Aktiengesellschaft worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.61 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sartorius Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sartorius Aktiengesellschaft (2013–2025)

The table below shows the annual total liabilities of Sartorius Aktiengesellschaft from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €5.85 Billion
≈ $6.84 Billion
-5.73%
2024-12-31 €6.21 Billion
≈ $7.25 Billion
-11.20%
2023-12-31 €6.99 Billion
≈ $8.17 Billion
+61.79%
2022-12-31 €4.32 Billion
≈ $5.05 Billion
+8.57%
2021-12-31 €3.98 Billion
≈ $4.65 Billion
+20.72%
2020-12-31 €3.30 Billion
≈ $3.85 Billion
+86.89%
2019-12-31 €1.76 Billion
≈ $2.06 Billion
+13.49%
2018-12-31 €1.55 Billion
≈ $1.82 Billion
+4.18%
2017-12-31 €1.49 Billion
≈ $1.74 Billion
+46.74%
2016-12-31 €1.02 Billion
≈ $1.19 Billion
+28.23%
2015-12-31 €792.48 Million
≈ $926.50 Million
+2.21%
2014-12-31 €775.37 Million
≈ $906.49 Million
+6.06%
2013-12-31 €731.07 Million
≈ $854.70 Million
--

About Sartorius Aktiengesellschaft

F:SRT Germany Medical Instruments & Supplies
Market Cap
$7.20 Billion
€6.16 Billion EUR
Market Cap Rank
#2868 Global
#563 in Germany
Share Price
€179.80
Change (1 day)
-2.71%
52-Week Range
€146.60 - €205.00
All Time High
€829.87
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more